Introduction
Several experiments regarding animals fed a cholesterol-rich diet (1) or subjected to balloon intravascular injury (2) have demonstrated that ethyl icosapentaenoate (EPA) inhibits intimal thickening of the arterial wall. Moreover, carotid arterial intimal thickening in rabbit carotid arteries, induced by cuff-sheathing, was also significantly suppressed by EPA (3). These findings suggested that EPA can inhibit intimal thickening in the early phase of arteriosclerosis. However, the mechanism by which EPA inhibits the arteriosclerotic process has not yet been fully understood because this process is associated with many other phenomena including interaction of cytokines and growth factors.
From this point of view, the rabbit model in which the carotid arteries are cuffsheathed is very useful to produce diffuse intimal thickening of the artery resembling the initial lesion of arteriosclerosis (4). Thus, to evaluate the effect of EPA on the metabolisms of tumor necrosis factor a (TNFa) and interleukin-1fi (IL-1p), the concentrations of TNFa and IL-1/3 were studied in the carotid arteries of rabbits sheathed in a cuff. The standard curves for TNFa and IL-1f were obtained before investigation with each standard sample of recombinant human TNFa and human IL-1/3, which had approximately 70% homology to rabbit TNFa and 74% homology to rabbit IL-1l at the amino acid level and cross-reactivity between two species, respectively (5, 6). In this study , reproducibility of the standard curve for both cytokine concentrations was also studied with correlation analysis . TNFa and IL-1/3 concentrations of the standard samples were determined twice after stepwise three-fold dilution of each standard sample with the buffer, which was used in determining tissue samples, in order to plot curves . Both correlation coefficients (mean +SE) of TNFa and IL-1 /3 (0.995+0.203 and 0.986+0.221, respectively) revealed excellent correlation, suggesting good reproducibility .
Protein was determined photometrically with a scanner according to the Lowry method (7). Concentrations of TNFa and IL-1l were expressed as pg/i/g protein . Four lanes consist of two lanes of standard sample (both side), two lanes of tissue sample (sample).
Statistical analysis
Statistical analysis was performed using Student's ttest with the Scheffe and Duncan test. A p-value of less than 0.05 was considered to indicate statistical significance.
Results

TNFa 1) Concentration at baseline in the control group
There was 43.5+3.0 pg/itg protein of TNFa just before cuff treatment (Table 1) .
2) Comparison of the concentration between two groups
The mean TNFa concentrations of the EPA group were significantly lower than those of the control group just before and 3 days after cuff treatment (Table 1) . At baseline, the TNFa concentration of the EPA group was 1/14 of that of the control group. No significant difference was seen between the two groups 7 days after cuff treatment.
3) Changes of the TNFa ratio between two groups
The ratio of TNFa concentration in the EPA group to that in the control group was lowest before cuff treatment and increased abruptly 3 days after cuff treatment (Fig. 3) . Seven days after cuff treatment, the ratio was approximately 1.0. Leukocyte proliferation and an increase of leukotrien (LT) B4 in the arterial wall were also observed early after cuffsheathing associated with partial desquamation of the endothelial cells. In the "response to injury" hypothesis on genesis of atherosclerosis proposed by Ross and Glomset (9, 10), it was considered that leukocytes play an important role in the initiation of arteriosclerotic lesions. These findings indicate that intimal thickening is not only the result of an inflammatory response, but also that this model could provide a sample of the early phase of atherosclerosis (11).
In this model, the histopathological and biochemical studies demonstrated that EPA significantly suppressed this intimal thickening of rabbit carotid arteries without lowering the levels of cholesterol (8). Furthermore, combined treatment with EPA and pravastatin reduced the serum levels of both cholesterol and triglyceride additively and complementarily and inhibited intimal thickening more strongly than did the respective monotherapy in this model (3). The mechanism of EPA to suppress atherothrombosis has been studied and it is well-known that EPA has a variety of actions on vascular biological phenomena.
EPA, co--3 fatty acid, enters the lipid bilayer of the cell membrane instead of co-6 fatty acid through plasma lipid, and modifies the function of membrane receptors and the eicosanoids metabolism in the cells. For example, EPA changes arachidonic acid metabolism both in platelets (12, 13) and endothelial cells (14-16), resulting in an anti-thrombotic action on the interface between the blood and vascular wall. These mechanisms explained the epidemiological evidence that the incidence of cardiovascular disease was extremely low in Eskimos, who used to have fish oil instead of meat (17).
In addition to anti-platelet actions, EPA has anti-inflammatory actions, which can suppress the inflammatory response in the arterial wall due to the effect of EPA on the eicosanoids (LTB4) metabolism in neutrophils (18) (19) (20) . Therefore, it was considered that one of the effects of EPA on intimal thickening after cuff-sheathing was due to suppression of LTB4 production.
On the other hand, it has been reported that fish oil decreased not only production of TNF and IL-1 by peripheral monocytes (21), but also production of PDGF by macrophages (22). However, there is little information on cytokines in this model, although cytokines play an important role in inflammation .
We thus conducted the present study to clarify the effect of EPA on the metabolism of inflammatory cytokines (IL-1 and TNF).
Applying this model, the effect of EPA on these cytokines was investigated within 1 week after cuff-sheathing, because it was clear that intimal thickening became apparent within a week (8). Moreover, animals were given a high dose of EPA for 1 week before cuff-sheathing so that their serum levels of EPA were the same as those of individuals treated with EPA.
In our study, there were 43.5 (+3.0) pg/Jug protein of TNFa and 53.5 (+4.8) pg/pg protein of IL-1/3 in the control group without cuff treatment, and significantly low concentrations of both TNFa and IL-1l in the EPA group. This suggested that these cytokines were present even in the normal vessel wall under preparation, and EPA could influence the metabolism of those cytokines in the arterial wall at baseline just before cuff-sheathing. Furthermore, EPA suppressed the production of TNFa in the early phase of intimal thickening, indicating a mechanism inhibiting the activation of smooth muscle cells such as their migration and proliferation induced by the cuffsheath method. However, this gives rise to two questions ; one concerning what kind of vascular cells are influenced by EPA, and the other regarding what the origin of these cytokines in the control group.
In general, TNFa is produced by macrophages, smooth muscle cells, and T-cells when they are activated . Although the origin and distribution of TNFa was not identified in this study, it is considered that some physical stimuli due to the exploration and ligation of the carotid arteries might activate these cells, especially the macrophages existing and circulating in the sample.
The origin of IL-1/3, produced by macrophages, smooth muscle cells, and endothelial cells, is also unknown, but physical stimuli might activate these cells as well as TNFa because mRNA of IL-1g could be immediately produced by the stimuli. Low concentrations of these cytokines in the EPA group suggested that paracrine and autocrine interactions between vascular cells secondary to cuffsheathing stimuli could be weak.
Further study will be needed to compare the mRNA levels of TNFa and IL-1/3 before cuff-sheathing stimuli to those after these stimuli , and to clarify the origin of these cytokines by immunohistochemical techniques.
In this study, the concentrations of these cytokines could not be compared directly between the samples obtained on different days. One of reason was that the concentrations were expressed as the ratio of cytokine weight to protein weight, each of which could influence the other. After cuff-sheathing, the vessel wall becomes swollen with the increase of the extracellular matrix as well as cell proliferation and formation of mural thrombi . Therefore, the ratios of TNFa and IL-1/3 concentrations in the EPA group to those in the control group were used as a marker, instead of these concentrations.
These findings suggested that EPA can inhibit intimal thickening in the pre-phase and the early phase of arteriosclerosis by suppression of the TNFa and IL-1/3 metabolisms.
EPA has also been reported to directly suppress smooth muscle cell proliferation (23) by inhibiting the binding of cytokines to their receptors on the surfaces of these cells. From this point of view, further study on the interactions among EPA, cytokines , and smooth muscle cells in the vessel wall should be performed coupling with each receptor, and using cytokines and antibodies specific for species.
Conclusion
To evaluate the effects of EPA on TNFa and IL-i/3 metabolisms in the thickening intima, the concentrations of these cytokines in the carotid arteries of rabbits sheathed in a cuff were studied using the Western blot method. The concentrations of both TNFa and IL-i/3 in the group pretreated with EPA for 1 week were significantly lower than in the control group even at baseline. Furthermore, EPA suppressed TNFa production 3 days after cuff-sheathing.
These findings suggested that EPA could influence the TNFa and IL-1/3 metabolisms in the arterial wall in the pre-phase and early phase of intimal thickening, indicating a mechanism inhibiting the activation of smooth muscle cells induced by the cuff-sheath method.
